US Army biodefense strategy says AI and biotechnology are lowering the barrier to engineering biological weapons
US Army · Strategy
Read the source (opens in a new tab)- What happened
- The US Army published its 2026 Army Biodefense Strategy, which sets goals to 2035 and opens with a foreword from the Secretary of the Army.
- Key points
- The foreword says "advanced biotechnology and artificial intelligence are dramatically lowering the barrier to engineering biological weapons" and calls this "a strategic threat."
- The strategy says advances in biotechnology, synthetic biology and AI "lower the barrier for developing novel biological weapons," for state and non-state actors alike.
- It makes biodefense "a core warfighting imperative" Army-wide, with five lines of effort so forces can "deploy, fight, and win decisively in a bio-contested environment" by 2035.
- It directs the Army to use AI and machine learning to analyze biosurveillance data, identify emerging threats and detect adversary misinformation about biological threats.
- Evidence
- The Army's own strategy document. It sets goals and tasks and says it will be carried out through "a detailed, separate implementation plan."